index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Biomarker Anti-interleukin-6 Lysosomal storage diseases Autoantibody Analyses multidimensionnelles Animals Autoantibodies Muscle Adverse drug reactions Active IMNM Male Deep immune profiling Immunotherapy Anti-Mi2 Anti-agalsidase antibodies Immune checkpoint inhibitors Case reports Inclusion body myositis Anémie hémolytique Inborn errors of metabolism Aldosterone Aged Bioelectrical impedance analysis Abnormal movement Adeno-associated vector Machine learning AAV vector Mass cytometry Adeno-associated virus Cardio-oncology Acute Kidney Injury/epidemiology/etiology IBM AAV humoral immunity Adjudication Autoimmunity Systems biology Antisynthétase Assisted communication devices Cytokines Multidisciplinarity Auto-antibodies Idiopathic inflammatory myopathies Biopsy Outcome measures Anti-MDA5 autoantibodies Sphingosine-1-phosphate Inflammation Anti‐mitochondrial antibodies AAV antibody Middle Aged Amyotrophy Anti-synthetase syndrome Prognosis Antibodies Biomarkers Myopathy Interstitial lung disease Fabry disease Female Myocarditis Arthritis Skeletal muscle Humans Myositis Anti-IgE IgG Gene therapy Agalsidase Dermatomyositis B-lymphocyte Antibody responses AAV Acid-alpha-glucosidase Dependovirus/genetics/immunology B cell homeostasis Anticorps spécifique des myosites Aldostérone Adeno-associated virus vector DM Adult Auto-immunité Auto‐antibodies AAV vectors Biomarqueurs Autoimmune diseases Myositis and muscle disease Adolescence Amyotrophic lateral sclerosis Cancer Antisynthetase syndrome Anticorps anti-agalsidase Pharmacology Anti-drug antibodies Inflammatory myopathy COVID-19 Data integration Polymyositis Antiphospholipid syndrome Antisynthetase Interferon